According to the SURMOUNT-1 clinical trial, a 72-week phase 3 study published in the New England Journal of Medicine involving over 2,500 participants, gastrointestinal side effects were the most commonly reported adverse events and were generally mild to moderate in severity
Dosing Schedules and Vial Usage Many people wonder how often they will need to replace a vial of semaglutide based on their dosage schedule
We hear about their challenges, their victories, and the small logistical hurdles that can make or break a health journey
The quality of compounded medications begins with high-grade Active Pharmaceutical Ingredients (APIs)
"It's important to monitor how you are responding to the medication, and that determines whether you go to the next dosage or remain on a lower dose." Starting right off at a high dose with the idea that it will "work faster" or be more effective isn't recommended because you're more likely to experience severe side effects, says Sowa
On 8 November 2023, Tirzepatide, branded as Zepbound in the US, received FDA approval as the first dual-target agonist for the treatment of obesity, further highlighting its potential in medical treatment options
